← Research LibraryThe BriefFY2026 10-K · headline figures audited against SEC data
Revenue increased 0.0% to $1.99B, while Net income increased 0.0% to $29.6M.
The read at a glance✓ Audited against SEC data
- Scale — FY2026 revenue $1.99BOK
- Profitability — Net income $29.6MOK
- Cash generation — Free cash flow $73.5MOK
- Accounting — Formula-grey distress score · no manipulation flag · earnings quality safeNote
- Insiders — 0 buys; 5 sells in 365 daysNote
- Capital — share repurchases were $3.2MNote
Business
National Vision Holdings, Inc.: If we fail to open and operate new stores in a timely and cost-effective manner or fail to successfully enter new markets, our financial performance could be materially adversely affected.
Where the revenue comes from
Fiscal 2025, as National Vision Holdings, Inc. reports it. History and quarterly detail are in the app.
- Products$1.6B
- Services and plans$385.4M
Leadership changes
From National Vision Holdings, Inc.'s own filings, the day they're filed.
- Reade Fahs · Chief Executive Officer · appointmenteff. 2025-08-01
- Alex Wilkes · Chief Executive Officer · appointmenteff. 2025-08-01
- National Vision · director · departureeff. 2023-12-07
Latest filings
- 10-Q · Quarterly report2026-08-13
- 8-K · Company announcement2026-08-12
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-14
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about National Vision Holdings, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.